Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Swedish (OMX) Pharma Industry Analysis

UpdatedOct 07, 2024
DataAggregated Company Financials
Companies30
  • 7D1.6%
  • 3M-3.2%
  • 1Y68.1%
  • YTDn/a

The Pharma industry is up 1.6% in the last week, with Camurus up 3.0%. This means that the industry has gained 68% over the past year. Looking forward, earnings are forecast to grow by 65% annually.

Industry Valuation and Performance

Has the Swedish Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 07 Oct 2024SEK 65.7bSEK 5.9b-SEK 1,157,224,367.43166.7x-56.8x11.2x
Wed, 04 Sep 2024SEK 68.3bSEK 5.9b-SEK 1,166,397,066.71181x-58.6x11.6x
Fri, 02 Aug 2024SEK 69.0bSEK 5.6b-SEK 992,819,149.4093.8x-69.4x12.3x
Sun, 30 Jun 2024SEK 66.9bSEK 6.4b-SEK 862,448,918.9878.1x-77.5x10.5x
Tue, 28 May 2024SEK 52.7bSEK 6.4b-SEK 766,474,388.9370.1x-68.7x8.3x
Thu, 25 Apr 2024SEK 48.3bSEK 6.2b-SEK 1,026,453,587.2677.7x-47x7.7x
Sat, 23 Mar 2024SEK 51.9bSEK 6.2b-SEK 1,038,101,124.2379.6x-50x8.3x
Mon, 19 Feb 2024SEK 47.2bSEK 6.1b-SEK 936,407,075.2980.6x-50.4x7.7x
Wed, 17 Jan 2024SEK 73.1bSEK 9.5b-SEK 1,182,170,641.0072x-61.8x7.7x
Fri, 15 Dec 2023SEK 66.4bSEK 9.4b-SEK 1,184,308,281.0062.9x-56.1x7x
Sun, 12 Nov 2023SEK 57.6bSEK 9.5b-SEK 1,251,439,555.0089.7x-46x6.1x
Tue, 10 Oct 2023SEK 50.3bSEK 9.2b-SEK 1,180,558,010.00112.8x-42.6x5.5x
Thu, 07 Sep 2023SEK 50.9bSEK 9.2b-SEK 1,177,933,599.00137.8x-43.2x5.5x
Sat, 05 Aug 2023SEK 51.5bSEK 8.9b-SEK 1,411,087,512.0086.2x-36.5x5.8x
Mon, 03 Jul 2023SEK 47.4bSEK 8.4b-SEK 1,692,681,920.0072.9x-28x5.7x
Wed, 31 May 2023SEK 48.6bSEK 8.4b-SEK 1,591,998,035.0079.8x-30.5x5.8x
Fri, 28 Apr 2023SEK 46.3bSEK 8.0b-SEK 1,784,037,428.0097.3x-25.9x5.8x
Sun, 26 Mar 2023SEK 44.6bSEK 8.0b-SEK 1,793,581,316.0083.8x-24.8x5.6x
Tue, 21 Feb 2023SEK 44.1bSEK 7.6b-SEK 2,033,810,225.00285.5x-21.7x5.8x
Thu, 19 Jan 2023SEK 49.0bSEK 7.3b-SEK 1,938,286,946.00287.4x-25.3x6.7x
Sat, 17 Dec 2022SEK 49.4bSEK 7.3b-SEK 1,876,123,734.00276.3x-26.3x6.8x
Mon, 14 Nov 2022SEK 49.2bSEK 6.8b-SEK 1,879,221,291.0057x-26.2x7.2x
Wed, 12 Oct 2022SEK 48.9bSEK 7.0b-SEK 1,739,998,147.0046.8x-28.1x7x
Fri, 09 Sep 2022SEK 51.3bSEK 7.0b-SEK 1,737,308,797.0053.8x-29.6x7.4x
Sun, 07 Aug 2022SEK 52.8bSEK 6.9b-SEK 1,535,185,603.0041.3x-34.4x7.7x
Tue, 05 Jul 2022SEK 52.7bSEK 5.9b-SEK 1,509,116,648.0042.2x-34.9x8.9x
Thu, 02 Jun 2022SEK 53.2bSEK 5.9b-SEK 1,514,835,101.0045x-35.1x9x
Sat, 30 Apr 2022SEK 54.7bSEK 5.5b-SEK 1,339,087,728.0038x-40.9x9.9x
Mon, 28 Mar 2022SEK 52.4bSEK 5.4b-SEK 1,308,660,882.0040.6x-40.1x9.7x
Wed, 23 Feb 2022SEK 48.7bSEK 5.3b-SEK 1,062,074,181.0077.5x-45.9x9.1x
Fri, 21 Jan 2022SEK 50.6bSEK 5.5b-SEK 1,083,517,936.00118.1x-46.7x9.3x
Sun, 19 Dec 2021SEK 54.0bSEK 5.5b-SEK 1,100,710,111.00109.6x-49.1x9.9x
Tue, 16 Nov 2021SEK 58.9bSEK 5.2b-SEK 1,372,634,926.0087.2x-42.9x11.2x
Thu, 14 Oct 2021SEK 52.4bSEK 4.8b-SEK 1,582,073,555.00141.9x-33.1x11x
Price to Earnings Ratio

-33.1x


Total Market Cap: SEK 52.4bTotal Earnings: -SEK 1,582,073,555.00Total Revenue: SEK 4.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Pharma Industry Price to Earnings3Y Average -42.3x202220232024
Current Industry PE
  • Investors are optimistic on the Swedish Pharmaceuticals industry, and appear confident in long term growth rates.
  • The 3-year average PS ratio of 8.0x is lower than the industry's current PS ratio of 11.2x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
  • Revenues for these companies have grown 7.2% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Comparison

How does Swedish Pharma compare with similar industries?

SE Market-1.29%
Healthcare-2.45%
Pharma1.61%
Pharma1.61%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CAMX CamurusSEK 659.503.0%
+SEK 1.1b		110.2%PE173.7x
CINPHA Cinclus Pharma HoldingSEK 29.224.3%
+SEK 56.5m		n/aPB2.1x
IRLAB A IRLAB TherapeuticsSEK 12.805.8%
+SEK 36.3m		91.0%PS16x
CLBIO Corline BiomedicalSEK 9.0614.4%
+SEK 24.5m		-37.7%PS6.8x
CALTX Calliditas TherapeuticsSEK 206.600.2%
+SEK 21.6m		103.1%PS7x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

ORX

SEK 14.40

Orexo

7D

3.6%

1Y

-13.6%

IRLAB A

SEK 12.80

IRLAB Therapeutics

7D

5.8%

1Y

91.0%

CSMED

DKK 7.94

CS Medica

7D

-19.0%

1Y

36.0%

CALTX

SEK 206.60

Calliditas Therapeutics

7D

0.2%

1Y

103.1%

DICOT

SEK 0.18

Dicot Pharma

7D

8.6%

1Y

24.9%

ENZY

SEK 1.90

Enzymatica

7D

-5.0%

1Y

-52.5%

CAMX

SEK 659.50

Camurus

7D

3.0%

1Y

110.2%

MOB

SEK 10.15

Moberg Pharma

7D

2.6%

1Y

47.1%

We're Hopeful That Moberg Pharma (STO:MOB) Will Use Its Cash Wisely

Sep 14
We're Hopeful That Moberg Pharma (STO:MOB) Will Use Its Cash Wisely

ODI

SEK 3.90

ODI Pharma

7D

-15.2%

1Y

-22.8%

PILA

SEK 5.40

Pila Pharma

7D

-10.0%

1Y

173.4%

CINPHA

SEK 29.22

Cinclus Pharma Holding

7D

4.3%

1Y

n/a

CLBIO

SEK 9.06

Corline Biomedical

7D

14.4%

1Y

-37.7%

SECARE

SEK 42.68

Swedencare

7D

-1.7%

1Y

9.8%

CESSA

DKK 14.25

Cessatech

7D

-14.2%

1Y

220.2%

Is Cessatech (NGM:CESSA) In A Good Position To Invest In Growth?

Aug 03
Is Cessatech (NGM:CESSA) In A Good Position To Invest In Growth?

FLERIE

SEK 41.71

Flerie

7D

-0.9%

1Y

n/a

KLAR

SEK 0.59

Klaria Pharma Holding AB (publ.)

7D

-27.4%

1Y

6.9%